Mizuho Securities analyst Anthony Petrone maintains $Intuitive Surgical (ISRG.US)$ with a hold rating, and adjusts the target price from $500 to $550.
According to TipRanks data, the analyst has a success rate of 51.4% and a total average return of 8.4% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Intuitive Surgical (ISRG.US)$'s main analysts recently are as follows:
Intuitive Surgical's Q3 earnings surpassed expectations, signaling a robust quarter propelled by significant placements of the Da Vinci 5 system, a strong increase in procedure volumes, and sustained margin discipline. Additionally, the company has elevated its FY24 procedure volume growth forecast to a range of 16%-17%, taking into account the potential for continued challenges in bariatric procedures and the impact of ongoing physician strikes in Korea, as well as the current state of affairs in China.
The sentiment that the market may be anticipating a substantial revenue outperformance for FY25 was expressed, particularly after the company's earnings report led to an approximate 3% increase in FY25 EPS estimates.
Intuitive Surgical exhibited 'strong' results for Q3, surpassing expectations in the two most crucial metrics - DV5 placements and procedure growth. Following the U.S. approval of the da Vinci 5, the company has quickly gained significant growth momentum. The early adoption of DV5 is progressing faster than the launch of the fourth-generation system, with promising indications of further growth acceleration as we approach 2025.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
瑞穗证券分析师Anthony Petrone维持$直觉外科公司 (ISRG.US)$持有评级，并将目标价从500美元上调至550美元。
根据TipRanks数据显示，该分析师近一年总胜率为51.4%，总平均回报率为8.4%。
此外，综合报道，$直觉外科公司 (ISRG.US)$近期主要分析师观点如下：
直觉外科公司的第三季度收益超过预期，表明由达芬奇5系统的大量放置、手术量显著增加以及持续的边际纪律推动的强劲季度。此外，公司已将其FY24手术量增长预测上调至16%-17%的区间，考虑到肥胖手术持续面临挑战以及韩国医生持续罢工的影响，以及目前中国事态的发展。
市场可能正在预期FY25的营业收入将有显著的超出表现，尤其是在公司的收益报告导致FY25每股收益估计大约增长3%后。
直觉外科公司展示了第三季度的“强劲”业绩，超出了最重要的两个指标的预期-达芬奇5的放置量和手术量增长。随着达芬奇5获得美国批准，公司迅速获得了显著的增长势头。与第四代系统的推出相比，DV5的早期采用速度更快，有迹象表明在我们接近2025年时将进一步加速增长。
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
